Search research articles
Contact Us
Filters
Showing results (71-80 of 155) with videos related to
Page
of 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2021
Cancer-specific loss of <i>TERT</i> activation sensitizes glioblastoma to DNA damage
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, et al.
Cancer Research
|
November 29, 2012
A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force
Stephan Beck, Bradley E Bernstein, Robert M Campbell, et al.
Nature Communications
|
September 16, 2022
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Carter J Barger, Abigail K Suwala, Katarzyna M Soczek, et al.
Neuro-Oncology
|
April 23, 2022
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma
Noriaki Minami, Donghyun Hong, Nicholas Stevers, et al.
Epigenetics
|
October 30, 2007
Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer
Joseph F Smith, Saleh Mahmood, Fei Song, et al.
Neuro-Oncology Advances
|
September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant glioma
Lindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Nature Communications
|
December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
Elliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Neuro-Oncology
|
November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors
Mohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Nature Reviews. Cancer
|
January 25, 2014
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm, Sebastian Bender, David T W Jones, et al.
Neuro-Oncology
|
March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Radhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 155) with videos related to
Sort By:
Page
of 16
Proceedings of the National Academy of Sciences of the United States of America
|
March 24, 2021
Cancer-specific loss of <i>TERT</i> activation sensitizes glioblastoma to DNA damage
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, et al.
Cancer Research
|
November 29, 2012
A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force
Stephan Beck, Bradley E Bernstein, Robert M Campbell, et al.
Nature Communications
|
September 16, 2022
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Carter J Barger, Abigail K Suwala, Katarzyna M Soczek, et al.
Neuro-Oncology
|
April 23, 2022
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma
Noriaki Minami, Donghyun Hong, Nicholas Stevers, et al.
Epigenetics
|
October 30, 2007
Identification of DNA methylation in 3' genomic regions that are associated with upregulation of gene expression in colorectal cancer
Joseph F Smith, Saleh Mahmood, Fei Song, et al.
Neuro-Oncology Advances
|
September 9, 2020
Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant glioma
Lindsey E Jones, Stephanie Hilz, Matthew R Grimmer, et al.
Nature Communications
|
December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
Elliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Neuro-Oncology
|
November 1, 2020
Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors
Mohith Manjunath, Jialu Yan, Yeoan Youn, et al.
Nature Reviews. Cancer
|
January 25, 2014
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm, Sebastian Bender, David T W Jones, et al.
Neuro-Oncology
|
March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Radhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Page
of 16